Search all trials

Find therapies in clinical trials near you – page 67

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Renal cell carcinoma stage IV+1

Not recruiting

Registered drugNo placebo

Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Glomerulonephritis membranoproliferative+1

Not recruiting

Registered drugNo placebo

Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pegcetacoplan

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Colon cancer

Not recruiting

Registered drugNo placebo

Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Bronchopulmonary dysplasia

Not recruiting

InvestigationalNo placebo

Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Mecasermin Rinfabate

Contact Research Centre

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study on Nemvaleukin Alfa and Pembrolizumab for Patients with Advanced Skin or Mucosal Melanoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Nemvaleukin Alfa

Contact Research Centre

Renal cancer metastatic

Not recruiting

Registered drug

Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Primary biliary cholangitis

Not recruiting

Investigational

Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Golexanolone

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

InvestigationalNo placebo

Study of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Retifanlimab

Contact Research Centre

Cervix carcinoma

Not recruiting

Registered drugNo placebo

Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Crisantaspase

Contact Research Centre

Neuroendocrine carcinoma metastatic

Not recruiting

Registered drugNo placebo

Study of Durvalumab, Carboplatin and Etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 67

810 trials match your criteria

Renal cell carcinoma stage IV+1

Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Glomerulonephritis membranoproliferative+1

Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Colon cancer

Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

Bronchopulmonary dysplasia

Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

Metastatic malignant melanoma

Study on Nemvaleukin Alfa and Pembrolizumab for Patients with Advanced Skin or Mucosal Melanoma

Renal cancer metastatic

Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

Primary biliary cholangitis

Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

Squamous cell carcinoma of head and neck

Study of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer

Cervix carcinoma

Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

Acute lymphocytic leukaemia

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Neuroendocrine carcinoma metastatic

Study of Durvalumab, Carboplatin and Etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.